| pubmed-article:12031328 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12031328 | lifeskim:mentions | umls-concept:C0031453 | lld:lifeskim |
| pubmed-article:12031328 | lifeskim:mentions | umls-concept:C0209606 | lld:lifeskim |
| pubmed-article:12031328 | lifeskim:mentions | umls-concept:C0243076 | lld:lifeskim |
| pubmed-article:12031328 | lifeskim:mentions | umls-concept:C0243072 | lld:lifeskim |
| pubmed-article:12031328 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:12031328 | pubmed:dateCreated | 2002-5-28 | lld:pubmed |
| pubmed-article:12031328 | pubmed:abstractText | Given the proposed involvement of VLA-4 in inflammatory processes, a program to identify orally active VLA-4 antagonists was initiated. Herein, we report the discovery of a N-tetrahydrofuroyl-(L)-phenylalanine derivative (17) and related analogues as potent VLA-4 antagonists with good oral bioavailability. | lld:pubmed |
| pubmed-article:12031328 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12031328 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12031328 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12031328 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12031328 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12031328 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12031328 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12031328 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12031328 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12031328 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12031328 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:12031328 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:12031328 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:12031328 | pubmed:author | pubmed-author:KidambiUshaU | lld:pubmed |
| pubmed-article:12031328 | pubmed:author | pubmed-author:EggerLinda... | lld:pubmed |
| pubmed-article:12031328 | pubmed:author | pubmed-author:MumfordRichar... | lld:pubmed |
| pubmed-article:12031328 | pubmed:author | pubmed-author:SchmidtJohn... | lld:pubmed |
| pubmed-article:12031328 | pubmed:author | pubmed-author:MacCossMalcol... | lld:pubmed |
| pubmed-article:12031328 | pubmed:author | pubmed-author:HagmannWillia... | lld:pubmed |
| pubmed-article:12031328 | pubmed:author | pubmed-author:ChangLinda... | lld:pubmed |
| pubmed-article:12031328 | pubmed:author | pubmed-author:TruongQuangQ | lld:pubmed |
| pubmed-article:12031328 | pubmed:author | pubmed-author:McCauleyErmen... | lld:pubmed |
| pubmed-article:12031328 | pubmed:author | pubmed-author:MagriotisPlat... | lld:pubmed |
| pubmed-article:12031328 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:12031328 | pubmed:author | pubmed-author:LiBingB | lld:pubmed |
| pubmed-article:12031328 | pubmed:author | pubmed-author:DohertyGeorge... | lld:pubmed |
| pubmed-article:12031328 | pubmed:author | pubmed-author:YangGinger... | lld:pubmed |
| pubmed-article:12031328 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12031328 | pubmed:day | 3 | lld:pubmed |
| pubmed-article:12031328 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:12031328 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12031328 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12031328 | pubmed:pagination | 1497-500 | lld:pubmed |
| pubmed-article:12031328 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12031328 | pubmed:meshHeading | pubmed-meshheading:12031328... | lld:pubmed |
| pubmed-article:12031328 | pubmed:meshHeading | pubmed-meshheading:12031328... | lld:pubmed |
| pubmed-article:12031328 | pubmed:meshHeading | pubmed-meshheading:12031328... | lld:pubmed |
| pubmed-article:12031328 | pubmed:meshHeading | pubmed-meshheading:12031328... | lld:pubmed |
| pubmed-article:12031328 | pubmed:meshHeading | pubmed-meshheading:12031328... | lld:pubmed |
| pubmed-article:12031328 | pubmed:meshHeading | pubmed-meshheading:12031328... | lld:pubmed |
| pubmed-article:12031328 | pubmed:meshHeading | pubmed-meshheading:12031328... | lld:pubmed |
| pubmed-article:12031328 | pubmed:meshHeading | pubmed-meshheading:12031328... | lld:pubmed |
| pubmed-article:12031328 | pubmed:meshHeading | pubmed-meshheading:12031328... | lld:pubmed |
| pubmed-article:12031328 | pubmed:meshHeading | pubmed-meshheading:12031328... | lld:pubmed |
| pubmed-article:12031328 | pubmed:meshHeading | pubmed-meshheading:12031328... | lld:pubmed |
| pubmed-article:12031328 | pubmed:meshHeading | pubmed-meshheading:12031328... | lld:pubmed |
| pubmed-article:12031328 | pubmed:meshHeading | pubmed-meshheading:12031328... | lld:pubmed |
| pubmed-article:12031328 | pubmed:meshHeading | pubmed-meshheading:12031328... | lld:pubmed |
| pubmed-article:12031328 | pubmed:meshHeading | pubmed-meshheading:12031328... | lld:pubmed |
| pubmed-article:12031328 | pubmed:meshHeading | pubmed-meshheading:12031328... | lld:pubmed |
| pubmed-article:12031328 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12031328 | pubmed:articleTitle | N-Tetrahydrofuroyl-(L)-phenylalanine derivatives as potent VLA-4 antagonists. | lld:pubmed |
| pubmed-article:12031328 | pubmed:affiliation | Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA. ginger_yang@merck.com | lld:pubmed |
| pubmed-article:12031328 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12031328 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:12031328 | lld:chembl |
